BioCryst Pharmaceuticals, Inc. EV/Sales

EV/Sales of BCRX for past 10 years: annual, quarterly and twelve month trailing (TTM) including EV/Sales growth rates and interactive chart. Compares the total enterprise value of a company to its sales. It is a more accurate measure of business value, as it takes into account cash and debt on the balance sheet. A company with large cash holdings and no debt will show a significantly lower EV/S than P/S ratio.

Highlights and Quick Summary

Current EV/Sales of BioCryst Pharmaceuticals, Inc. is 16.31 (as of December 31, 2021)
  • EV/Sales for the quarter ending September 30, 2022 was 11.07 (a 3.61% increase compared to previous quarter)
  • Year-over-year quarterly EV/Sales decreased by -32.12%
  • Annual EV/Sales for 2021 was 16.31 (a -76.25% decrease from previous year)
  • Annual EV/Sales for 2020 was 68.66 (a 965.34% increase from previous year)
  • Annual EV/Sales for 2019 was 6.45 (a -82.47% decrease from previous year)
Visit stockrow.com/BCRX for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EV/Sales of BioCryst Pharmaceuticals, Inc.

Most recent EV/Salesof BCRX including historical data for past 10 years.

Interactive Chart of EV/Sales of BioCryst Pharmaceuticals, Inc.

BioCryst Pharmaceuticals, Inc. EV/Sales for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 – 11.07 10.68 16.87 –
2021 16.31 23.51 36.55 57.68 16.31
2020 68.66 9.56 12.85 5.19 68.66
2019 6.45 25.09 31.86 38.37 6.45
2018 36.77 31.14 16.98 19.41 36.77
2017 14.6 10.12 13.21 17.94 14.6
2016 16.62 13.48 6.82 3.74 16.62
2015 14.54 16.16 24.63 36.11 14.54
2014 56.51 32.3 39.67 36.49 56.51
2013 23.74 37.1 5.96 4.06 23.74
2012 2.45 7.55 7.16 8.32 2.45

Business Profile of BioCryst Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology
© stockrow.com